[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368878-105":59,"doc-detail-368878-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-immune-microenvironment-of-pathogen-associated-cancers-and-current-clinical-therapeutics","The immune microenvironment of pathogen-associated cancers and current clinical therapeutics","","Pathogen-associated cancers make up roughly 15–20% of malignancies worldwide, driven by chronic infections from oncogenic viruses, bacteria, and parasites. These pathogens remodel the tumor microenvironment (TME) into an immune-suppressive niche through mechanisms such as immune checkpoint manipulation, chronic inflammation, metabolic reprogramming, and epigenetic alterations. Infection-linked immune dysfunctions include M2-polarized macrophages, expanded MDSCs, exhausted T/NK cells, and tolerogenic dendritic cells, promoting immune evasion and treatment resistance. Therapeutic progress spans prophylactic vaccines, immune checkpoint inhibitors, and engineered delivery approaches such as Salmonella targeting hypoxic tumors and the microbiome, alongside challenges like pathogen heterogeneity and limited biomarkers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-immune-microenvironment-of-pathogen-associated-cancers-and-current-clinical-therapeutics/368878/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-immune-microenvironment-of-pathogen-associated-cancers-and-current-clinical-therapeutics/368878.png","ImageObject",300,407,{"name":92,"@type":93},"Mary Man","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role do oncogenic pathogens play in pathogen-associated cancers?","Question",{"text":112,"@type":113},"They arise from chronic infections by oncogenic viruses, bacteria, and parasites that contribute to carcinogenesis and immune evasion within the tumor microenvironment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do pathogens reshape the tumor microenvironment (TME)?",{"text":117,"@type":113},"They alter the TME toward immune suppression via immune checkpoint manipulation, chronic inflammation, metabolic reprogramming, and direct epigenetic modifications.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic strategies are discussed for pathogen-associated cancers?",{"text":121,"@type":113},"The review covers prophylactic vaccines, immune checkpoint inhibitors, and next-generation approaches such as engineered Salmonella delivery to hypoxic tumors and microbiome targeting, while noting challenges like biomarker absence and safety/scale considerations.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368878,1790330560,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Wei et al. Molecular Cancer (2025) 24:232 [https://doi.org/10.1186/s12943-025-02448-x](https://doi.org/10.1186/s12943-025-02448-x)  \nMolecular Cancer  \nRESEARCH Open Access  \nThe immune microenvironment of pathogenassociated cancers and current clinical therapeutics  \nXiao-Yu Wei 1, Hui-Jing Feng2, Ying-Yin Zhu3, Shi-Jing Guo4, Hong Wang3, Ming Li5* and Qi Mei2*  \nAbstract  \nPathogen-associated cancers account roughly 15–20% of all malignancies worldwide and arise from chronic infections by oncogenic viruses, bacteria and parasites. Pathogens can alter the tumor microenvironment (TME) into an immune-suppressive niche using multiple mechanisms, including immune checkpoint manipulation, chronic inflammation, metabolic reprogramming, and direct epigenetic modifications. Immune dysfunctions related to infections linked to cancers can include M2-polarized macrophages, expansion of MDSCs, exhausted T/NK cells, and tolerogenic dendritic cells, all progressing immune evasion and resistance to cancer therapy. Advancesin therapeutics exist in prophylactic vaccines, immune checkpoint inhibitors, and next-generation methods such as the engineered Salmonella to deliver to hypoxic tumors and the targeting the microbiome. The advancement of pathogen-, cancer-, and patient-specific therapeutics is not without its challenges, including heterogeneity of the pathogens, absence of clinically useful biomarkers, concerns about the safety of the restoring anti-pathogen immunity and challenges of scale for manifold interventions. This review will provide a synthesis of the mechanistic aspects of pathogen-mediated TME remodeling, contemporary clinical therapeutics, and ongoing investigations into using pathogen/host dynamics to enhance measurable precision immunotherapy strategies.  \nKeywords Oncogenic pathogens , Pathogen-associated cancers, Tumor microenvironment (TME), Immunosuppressive mechanisms, Immunotherapy  \n*Correspondence: Ming Li[limm2021@126.com](limm2021@126.com)[ ](limm2021@126.com)Qi Mei [borismq@163.com](borismq@163.com)  \n1The Department of Infectious Disease, The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing 402160, China  \n2Cancer Center, Tongji Shanxi Hospital, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Taiyuan 030032, Shanxi, China  \n3The department of radiology, Suzhou 100 Hospital, Suzhou city 215000, Jiangsu province, China  \n4The North Sichuan Medical College, Nanchong City 637000, Sichuan province, China  \n5The Jiangsu Subei People’s Hospital (Affiliated Hospital of Yangzhou University), Yangzhou 225009, China  \nIntroduction  \nCancer is a significant global health threat, and a large percentage of tumors are attributable to chronic infections by oncogenic pathogens, including viruses, bacteria and parasites [1]. These pathogens use host immunity to create chronic infections, in a tumor-permissive microenvironment that is characterized by immune evasion,  \nchronic inflammation and stromal remodeling [2].  \nTumor microenvironments (TMEs) in pathogen-associated cancers are defined by a reciprocal relationship between the host’s immune cells and microbial factors, causing carcinogenesis due to immune evasion that leads to genomic instability, inappropriate cytokine signaling and recruitment of immune suppressive cells [3]. For  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in th","cbCaiqnlijgCVLPc","https://ap.wps.com/l/cbCaiqnlijgCVLPc","pdf",4760136,18,"English","# Abstract\n# Introduction","[{\"question\":\"What role do oncogenic pathogens play in pathogen-associated cancers?\",\"answer\":\"They arise from chronic infections by oncogenic viruses, bacteria, and parasites that contribute to carcinogenesis and immune evasion within the tumor microenvironment.\"},{\"question\":\"How do pathogens reshape the tumor microenvironment (TME)?\",\"answer\":\"They alter the TME toward immune suppression via immune checkpoint manipulation, chronic inflammation, metabolic reprogramming, and direct epigenetic modifications.\"},{\"question\":\"What therapeutic strategies are discussed for pathogen-associated cancers?\",\"answer\":\"The review covers prophylactic vaccines, immune checkpoint inhibitors, and next-generation approaches such as engineered Salmonella delivery to hypoxic tumors and microbiome targeting, while noting challenges like biomarker absence and safety/scale considerations.\"}]","The immune microenvironment of pathogen-associated cancers and current clinical therapeutics | PDF",1790179043,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b1bd76ad8c33233365f18ed33c7038d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50506b964e96f72d7091ecdabcd78519.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f3ec9e67c00575f2ee7875a520949a3.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da86dcb50dcd6169006ab952b6ed8f3a.webp",980,1306]